New drug MH-001 takes first step: tested in healthy volunteers
Knowledge-focused
Completed
This early-stage study tested a new drug, MH-001, in 58 healthy adults to see if it is safe and how the body handles it. Participants received either the drug or a placebo in single or multiple doses. The main goal was to check for any side effects, with no direct treatment benef…
Phase: PHASE1 • Sponsor: Vespina Lifesciences Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC